Glioblastoma-associated stromal cells (GASCs) from histologically normal surgical margins have a myofibroblast phenotype and angiogenic properties

Anti-S100A4 Antibody Suppresses Metastasis Formation by Blocking Stroma Cell Invasion

(2015) Jörg Klingelhöfer et al.   NEOPLASIA

Gene Expression Profile Identifies Tyrosine Kinase c-Met as a Targetable Mediator of Antiangiogenic Therapy Resistance

(2013) A. Jahangiri et al.   CLINICAL CANCER RESEARCH

Glioblastoma Resistance to Anti-VEGF Therapy: Has the Challenge Been MET?

(2013) J. H. McCarty   CLINICAL CANCER RESEARCH

Carcinoma-associated fibroblasts: Non-neoplastic tumour-promoting mesenchymal cells

(2013) Urszula M. Polanska et al.   JOURNAL OF CELLULAR PHYSIOLOGY

Breast stromal fibroblasts from histologically normal surgical margins are pro-carcinogenic

(2013) Maha A Al-Rakan et al.   JOURNAL OF PATHOLOGY

Effects of Dual Targeting of Tumor Cells and Stroma in Human Glioblastoma Xenografts with a Tyrosine Kinase Inhibitor against c-MET and VEGFR2

(2013) Anna C. Navis et al.   PLoS One

Improved tumor oxygenation and survival in glioblastoma patients who show increased blood perfusion after cediranib and chemoradiation

(2013) T. T. Batchelor et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

‘Cancer associated fibroblasts’ – more than meets the eye

(2013) Shalom Madar et al.   TRENDS IN MOLECULAR MEDICINE

Glioblastoma angiogenesis: VEGF resistance solutions and new strategies based on molecular mechanisms of tumor vessel formation

(2012) Shingo Takano   Brain Tumor Pathology

VEGF Inhibits Tumor Cell Invasion and Mesenchymal Transition through a MET/VEGFR2 Complex

(2012) Kan V. Lu et al.   CANCER CELL

Anti-VEGF/VEGFR Therapy for Cancer: Reassessing the Target

(2012) B. Sitohy et al.   CANCER RESEARCH

The influence of surgery on recurrence pattern of glioblastoma

(2012) Pasquale De Bonis et al.   CLINICAL NEUROLOGY AND NEUROSURGERY

In vitro studies of actin filament and network dynamics

(2012) R Dyche Mullins et al.   CURRENT OPINION IN CELL BIOLOGY

Failure pattern following complete resection plus radiotherapy and temozolomide is at the resection margin in patients with glioblastoma

(2012) Kevin Petrecca et al.   JOURNAL OF NEURO-ONCOLOGY

From sentinel cells to inflammatory culprits: cancer-associated fibroblasts in tumour-related inflammation

(2012) Charlotte Servais et al.   JOURNAL OF PATHOLOGY

Overexpression of thrombospondin-1 in stromal myofibroblasts is associated with tumor growth and nodal metastasis in gastric carcinoma

(2012) Xian-Dong Lin et al.   JOURNAL OF SURGICAL ONCOLOGY

Galectin-1, a gene preferentially expressed at the tumor margin, promotes glioblastoma cell invasion

(2012) L Toussaint et al.   Molecular Cancer

ApoB-containing lipoproteins regulate angiogenesis by modulating expression of VEGF receptor 1

(2012) Inbal Avraham-Davidi et al.   NATURE MEDICINE

Tumor angiogenesis is enforced by autocrine regulation of high-mobility group box 1

(2012) J R van Beijnum et al.   ONCOGENE

Glioblastoma Recurrence after Cediranib Therapy in Patients: Lack of "Rebound" Revascularization as Mode of Escape

(2011) E. di Tomaso et al.   CANCER RESEARCH

Isolation of a new cell population in the glioblastoma microenvironment

(2011) Anne Clavreul et al.   JOURNAL OF NEURO-ONCOLOGY

 B-Crystallin, an Effector of Unfolded Protein Response, Confers Anti-VEGF Resistance to Breast Cancer via Maintenance of Intracrine VEGF in Endothelial Cells

(2011) Q. Ruan et al.   MOLECULAR CANCER RESEARCH

Anti-VEGF treatment reduces blood supply and increases tumor cell invasion in glioblastoma

(2011) Olivier Keunen et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Focal Adhesion Assembly in Myofibroblasts Fosters a Microenvironment that Promotes Tumor Growth

(2010) Ningling Kang et al.   AMERICAN JOURNAL OF PATHOLOGY

High-mobility group box 1 and cancer

(2010) Daolin Tang et al.   Biochimica et Biophysica Acta-Gene Regulatory Mechanisms

Mesenchymal stem cells as cellular vehicles for delivery of nanoparticles to brain tumors

(2010) Mathilde Roger et al.   BIOMATERIALS

Angiopoietin-4 Promotes Glioblastoma Progression by Enhancing Tumor Cell Viability and Angiogenesis

(2010) M. K. Brunckhorst et al.   CANCER RESEARCH

Interleukin-8 Mediates Resistance to Antiangiogenic Agent Sunitinib in Renal Cell Carcinoma

(2010) D. Huang et al.   CANCER RESEARCH

Fibroblast growth factor 2 regulates endothelial cell sensitivity to sunitinib

(2010) J C Welti et al.   ONCOGENE

 B-crystallin regulation of angiogenesis by modulation of VEGF

(2009) S. Kase et al.   BLOOD

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

(2009) Roger Stupp et al.   LANCET ONCOLOGY

The nuances of therapy

(2009) Lee M. Ellis et al.   NATURE

Actin, a Central Player in Cell Shape and Movement

(2009) T. D. Pollard et al.   SCIENCE

A crucial role of caldesmon in vascular development in vivo

(2008) P.-P. Zheng et al.   CARDIOVASCULAR RESEARCH

Environmental sensing through focal adhesions

(2008) Benjamin Geiger et al.   NATURE REVIEWS MOLECULAR CELL BIOLOGY

Improved proteome coverage by using iTRAQ labelling and peptide OFFGEL fractionation

(2008) Emilie Ernoult et al.   Proteome Science